Osivax reports phase 2b data for OVX836
Results support combination strategy for influenza vaccines
Read More
Author: John Pinching
Merz completes phase 3 recruitment for XEOMIN
Global trials assess migraine prevention potential
Read More
CHMP backs TALVEY plus daratumumab for earlier myeloma use
Recommendation supports second-line combination option
Read More
CHMP backs RASONQUE for metastatic pancreatic cancer
Positive opinion supports EU marketing authorisation
Read More
Libtayo dosing backed by CHMP
Regimen update recommended across all indications
Read More
